WHO ICTRP trial
Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel…
JPRN-UMIN000010055 · Japan Primary Registries Network (JPRN) · Recruiting
Key facts
| Trial ID | JPRN-UMIN000010055 |
|---|---|
| Public title | Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapy |
| Scientific title | Phase II study evaluating the efficacy and safety of the Bevacizumab / Docetaxel maintenance therapy beyond stable disease in patients with advanced relapsed non-squamous NSCLC who received Bevacizumab / pemetrexed / platinum induction therapy - Phase II study evaluating the efficacy and safety of… |
| Primary sponsor | Respiratory Center, Showa University Northern Yokohama Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase II |
| Countries | Japan |
| Conditions | advanced relapsed non-squamous NSCLC |
| Interventions | If the disease is stable after four courses of CBDCA+PEM+BEV as induction therapy, patients will be treated with DTX+BEV as maintenance therapy until progression disease. |
| Registration date | Feb 18, 2013 |
| Target size | 20 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: